Mian-Yoon Chong

656 total citations
15 papers, 342 citations indexed

About

Mian-Yoon Chong is a scholar working on Psychiatry and Mental health, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, Mian-Yoon Chong has authored 15 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 6 papers in Pharmacology and 5 papers in Experimental and Cognitive Psychology. Recurrent topics in Mian-Yoon Chong's work include Schizophrenia research and treatment (9 papers), Treatment of Major Depression (5 papers) and Bipolar Disorder and Treatment (4 papers). Mian-Yoon Chong is often cited by papers focused on Schizophrenia research and treatment (9 papers), Treatment of Major Depression (5 papers) and Bipolar Disorder and Treatment (4 papers). Mian-Yoon Chong collaborates with scholars based in Taiwan, Japan and Singapore. Mian-Yoon Chong's co-authors include Andrew T. A. Cheng, Cheng‐Fang Yen, Susan Shur‐Fen Gau, Kung‐Yee Liang, Naotaka Shinfuku, Norman Sartorius, Kang Sim, Ee Heok Kua, Hin‐Yeung Tsang and Tianmei Si and has published in prestigious journals such as The British Journal of Psychiatry, Journal of Affective Disorders and Journal of Clinical Psychopharmacology.

In The Last Decade

Mian-Yoon Chong

15 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mian-Yoon Chong Taiwan 11 192 118 48 46 44 15 342
S Pirzada Sattar United States 11 132 0.7× 99 0.8× 63 1.3× 24 0.5× 42 1.0× 24 390
Xingjia Cui United States 9 149 0.8× 113 1.0× 78 1.6× 55 1.2× 31 0.7× 12 443
Denise Hanssen Netherlands 10 140 0.7× 86 0.7× 34 0.7× 44 1.0× 25 0.6× 33 321
Ruth Morin United States 12 107 0.6× 135 1.1× 19 0.4× 40 0.9× 51 1.2× 28 332
Aske Astrup Denmark 9 158 0.8× 142 1.2× 25 0.5× 53 1.2× 57 1.3× 11 405
Cris Henderson United States 4 322 1.7× 99 0.8× 28 0.6× 97 2.1× 48 1.1× 8 458
Leo Bastiaens United States 10 117 0.6× 125 1.1× 29 0.6× 32 0.7× 35 0.8× 27 295
Hari Subramaniam United Kingdom 7 157 0.8× 46 0.4× 58 1.2× 56 1.2× 48 1.1× 21 341
Peter H. Hilderink Netherlands 8 186 1.0× 65 0.6× 38 0.8× 22 0.5× 15 0.3× 13 298
Sriram Ramaswamy United States 12 120 0.6× 129 1.1× 74 1.5× 22 0.5× 51 1.2× 33 446

Countries citing papers authored by Mian-Yoon Chong

Since Specialization
Citations

This map shows the geographic impact of Mian-Yoon Chong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mian-Yoon Chong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mian-Yoon Chong more than expected).

Fields of papers citing papers by Mian-Yoon Chong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mian-Yoon Chong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mian-Yoon Chong. The network helps show where Mian-Yoon Chong may publish in the future.

Co-authorship network of co-authors of Mian-Yoon Chong

This figure shows the co-authorship network connecting the top 25 collaborators of Mian-Yoon Chong. A scholar is included among the top collaborators of Mian-Yoon Chong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mian-Yoon Chong. Mian-Yoon Chong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Park, Seon‐Cheol, Adarsh Tripathi, Roy Abraham Kallivayalil, et al.. (2019). Cannabis use correlates with aggressive behavior and long-acting injectable antipsychotic treatment in Asian patients with schizophrenia. Nordic Journal of Psychiatry. 73(6). 323–330. 11 indexed citations
3.
Zeng, Liang-Nan, Qinge Zhang, Shu-Yu Yang, et al.. (2019). Antipsychotic Polypharmacy in Older Adult Asian Patients With Schizophrenia: Research on Asian Psychotropic Prescription Pattern. Journal of Geriatric Psychiatry and Neurology. 32(6). 304–311. 12 indexed citations
4.
Park, Yong Chon, Shu-Yu Yang, Mian-Yoon Chong, et al.. (2018). Differences in High Dose Antipsychotic Prescriptions in Patients with Schizophrenia in Asian Countries/Areas: Findings from the REAP-AP Study. Psychiatry Investigation. 15(10). 1007–1008. 7 indexed citations
5.
Yang, Shu-Yu, Ramin Mojtabai, Yan-Ling He, et al.. (2018). Trends of Polypharmacy and Prescription Patterns of Antidepressants in Asia. Journal of Clinical Psychopharmacology. 38(6). 598–603. 9 indexed citations
6.
Park, Seon‐Cheol, Min-Soo Lee, Sang‐Woo Hahn, et al.. (2017). Clinical Characteristics and Psychotropic Prescribing Patterns Associated with impaired Concentration in Asians with Depressive Disorders: The REAP-AD Study. The Tohoku Journal of Experimental Medicine. 242(2). 151–156. 1 indexed citations
7.
Park, Seon‐Cheol, Min-Soo Lee, Sang‐Woo Hahn, et al.. (2016). Suicidal thoughts/acts and clinical correlates in patients with depressive disorders in Asians: results from the REAP-AD study. Acta Neuropsychiatrica. 28(6). 337–345. 17 indexed citations
8.
Lin, Pei‐Wen, et al.. (2013). Antidepressant-induced Tardive Syndrome: a Retrospective Epidemiological Study. Pharmacopsychiatry. 46(7). 281–285. 13 indexed citations
9.
Xiang, Yu‐Tao, Chuanyue Wang, Tianmei Si, et al.. (2011). Antipsychotic Polypharmacy in Inpatients with Schizophrenia in Asia (2001−2009). Pharmacopsychiatry. 45(1). 7–12. 41 indexed citations
10.
Xiang, Yu‐Tao, Chuanyue Wang, Tianmei Si, et al.. (2011). Tardive dyskinesia in the treatment of schizophrenia: the findings of the Research on Asian Psychotropic Prescription Pattern (REAP) survey (2001 – 2009). International Journal of Clinical Pharmacology and Therapeutics. 49(6). 382–387. 10 indexed citations
11.
Xiang, Yu‐Tao, Chuanyue Wang, Tianmei Si, et al.. (2011). Use of Anticholinergic Drugs in Patients with Schizophrenia in Asia from 2001 to 2009. Pharmacopsychiatry. 44(3). 114–118. 13 indexed citations
12.
Cheng, Andrew T. A., Keith Hawton, Chien‐Jen Chen, et al.. (2007). The influence of media reporting of a celebrity suicide on suicidal behavior in patients with a history of depressive disorder. Journal of Affective Disorders. 103(1-3). 69–75. 45 indexed citations
13.
Gau, Susan Shur‐Fen, et al.. (2006). Psychiatric and psychosocial predictors of substance use disorders among adolescents. The British Journal of Psychiatry. 190(1). 42–48. 86 indexed citations
14.
Sim, Kang, Alex Su, Mian-Yoon Chong, et al.. (2004). High Dose Antipsychotic Use in Schizophrenia: Findings of the REAP (Research on East Asia Psychotropic Prescriptions) Study. Pharmacopsychiatry. 37(4). 175–179. 48 indexed citations
15.
Chen, Cheng‐Sheng, et al.. (2000). Validation of the Chinese Health Questionnaire (CHQ-12) in community elders.. PubMed. 16(11). 559–65. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026